Construction of a Multi-tenant Centre with Laboratories for Life Sciences Companies in Sherbrooke

SHERBROOKE, QC, March 23, 2017 /CNW Telbec/ - Sherbrooke Innopole and its partners officially launched the construction of the scientific multi-tenant centre EspaceLabz on March 22nd, in attendance of 60 guests from the business community and the institutional sector.

The centre is to be built in the Sherbrooke Science Park, next to the biopharmaceutical company Charles River and the Université de Sherbrooke's Health Campus. It will cover 20 000 sq. ft. over two floors and contain offices of various dimensions, private laboratories, and shared laboratories with a range of specialized equipment. The model also includes common areas, like a conference room and lounge area. 

The project, an initiative of Sherbrooke Innopole, entails $5.5M in investments, and its business plan forecasts the creation of 60 jobs within the next 5 years. It is the result of a partnership with the City of Sherbrooke, the Comité de promotion industrielle de Brompton (CPIB – Brompton's industrial promotion committee) and the Comité de promotion industrielle de Sherbrooke (CPIS – Sherbrooke's industrial promotion committee).

Sherbrooke Mayor Bernard Sévigny highlighted the importance of this infrastructure: "We are fortunate to be a university city with a tremendous potential for the creation of technological businesses, however, we must provide the environment and conditions to foster their development here," he explained. "The City of Sherbrooke is proud to support this project, as it is an essential tool for economic development and the retention of start-ups in the Life Sciences sector as well as the attraction of foreign companies." 

Several companies have confirmed their intention to move into EspaceLabz, including the multinational VWR International, which will occupy a space in the building, and whose equipment will be available for use by other centre tenants, as well as Immune Biosolutions, a young Sherbrooke company that develops antibodies using hen's eggs. Construction will be completed in summer 2017.

SOURCE Sherbrooke Innopole

Marie-Eve Poliquin, director of communications, Sherbrooke Innopole, 819 345-9849, 819 821-5577, [email protected]